NCT02473042View on ClinicalTrials.gov

Intraoperative Acupoint Stimulation to Prevent Post-Operative Nausea and Vomiting (PONV)

NACompletedINTERVENTIONAL
Enrollment

187

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

November 26, 2024

Study Completion Date

November 26, 2024

Conditions
Post-Operative Nausea and VomitingBreast Cancer
Interventions
PROCEDURE

Electrical Stimulation

Electrical stimulation to the wrist initiated at 1mHz, 1 pulse/second using two leads on a nerve stimulator. Stimulation continued throughout the breast surgery.

DRUG

Zofran

4 mg by vein for 1 dose.

DRUG

Dexamethasone

10 mg by vein for 1 dose.

DRUG

Phenergan

6.25 mg by vein for 1 dose.

DRUG

Pepcid

10 mg by vein for 1 dose.

BEHAVIORAL

Questionnaire

Questionnaire completed about 15 minutes after participant wakes up after surgery, then every 30 minutes until they leave the clinic. It should take about 2 - 3 minutes to complete the questionnaire.

Trial Locations (1)

77030

University of Texas MD Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER

NCT02473042 - Intraoperative Acupoint Stimulation to Prevent Post-Operative Nausea and Vomiting (PONV) | Biotech Hunter | Biotech Hunter